Common mistakes with AOD-9604
Avoid the most common pitfalls when working with AOD-9604 in a research setting: storage, reconstitution, concentration, and COA verification mistakes.
Mistake 1: Improper storage after reconstitution
Once AOD-9604 is reconstituted with bacteriostatic water, it must be stored at 2-8°C (refrigerated) and used within 28 days. A common mistake is leaving the vial at room temperature for extended periods, which degrades the peptide and can invalidate experimental results.
Freeze-thaw cycles are another issue — each cycle reduces peptide integrity. If your protocol requires long-term storage, keep the lyophilised vial frozen at -20°C until the moment of reconstitution.
Mistake 2: Concentration miscalculation
Calculating the target concentration wrong is one of the most common experimental errors with AOD-9604. Always double-check:
- The stated vial mass (e.g. 5mg, 10mg)
- The volume of bacteriostatic water added
- The resulting concentration (mass / volume)
- The volume of reconstituted solution you draw into the syringe for each dose point
A simple spreadsheet or lab notebook with these values at the top of every experiment can prevent costly errors.
Mistake 3: Skipping COA verification
Researchers sometimes trust a supplier's purity claim without checking the actual COA. For AOD-9604, always:
- Match the batch number on your vial to the COA on the product page
- Verify the HPLC chromatogram shows a single clean peak
- Confirm the mass spectrometry reading matches the theoretical molecular weight
- Check the expiry date
Skipping this step means you are treating purity as a marketing claim rather than a verifiable fact. Peptify publishes every batch COA at peptifyuk.com, downloadable directly from each product page.
Buy AOD-9604 for research
99%+ HPLC-verified AOD-9604 in stock. Every vial ships from the UK with a batch-specific Certificate of Analysis. Same-day dispatch on orders before 1pm.
Frequently asked questions
What is AOD-9604?
AOD-9604 is a synthetic fragment of the human growth hormone molecule, specifically the lipolytic-pathway domain. It is studied in adipose-pathway research without effects on somatotropic or glycaemic markers.